glp 1 drugs and blood clots April 2025 PEP Talk: Weight, Clots, GLP-1 GLP-1 Therapies May Benefit MPN
Description
In addition, researchers determined that participants taking retatrutide had not yet reached a weight loss plateau at 80 weeks, meaning continued treatment would likely produce further weight loss
These medications required extensive clinical trials, FDA review, and ongoing medical supervision
But theyre tools, not solutions
Skipping meals or over-restricting calories while using appetite-support products may cause fatigue or nutrient deficiency
GLP-1 receptor agonists potential therapeutic effects appear to target key pathological mechanisms of PD directly
Retrieved 12 September 2024.
